logo
NasdaqCM:RCEL logo

AVITA Medical Community

NasdaqCM:RCEL Community
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 25 Fair Values set on narratives written by author
Create a narrative

Community Investing Ideas

RCEL logo
AVITA Medical
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts

PermeaDerm And Cohealyx Will Open International Markets

Key Takeaways Launching new products and expanding internationally are expected to drive significant revenue growth and market penetration. Strategic focus on accelerating healing solutions aims to reduce costs and improve adoption rates, potentially boosting net margins.
View narrative
US$17.39
FV
45.6% undervalued intrinsic discount
43.82%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
15users have followed this narrative
7 days ago author updated this narrative